Clinical trial
Treatment of Adults With Growth Hormone Deficiency
NCT00294619 · LG Life Sciences, Industry · Completed
Key facts
| NCT number | NCT00294619 |
|---|---|
| Title | Treatment of Adults With Growth Hormone Deficiency |
| Official title | A Phase III, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess Efficacy and Safety of LB03002 Administered Weekly in Adults With Growth Hormone Deficiency. |
| Lead sponsor | LG Life Sciences, Industry |
| Collaborators | BioPartners GmbH Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pituitary Disorders, Adult Growth Hormone Deficiency |
| Intervention type | Drug |
| Interventions | growth hormone |
| Enrollment | 147 |
| Start date | Apr 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Feb 22, 2006 |
| Last update posted | Oct 5, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: